INMED PHARMACEUTICALS (IMLFF) earnings
IMLFF earnings moved a median of -2.18% by the close. Quarterly and annual IMLFF reports and results, each read against the price at its own news timestamp. Back to the IMLFF overview →
14 measured IMLFF earnings events.
Where these IMLFF earnings landedvs 14 measured IMLFF earnings reactions
| Middle 50% of IMLFF earnings reactions | -5.14% to -1.02% |
|---|---|
| Median reaction (to close) | -2.18% |
| Measured reactions | 14 |
Point-in-time · zero look-ahead
Half of the 14 IMLFF earnings events with a measured close landed between -5.14% and -1.02%; 14% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-K InMed Pharmaceuticals For: Jun 30 | SEC filing · Form 10-K | +0.00% | +0.00% | |
| Form 10-Q InMed Pharmaceuticals For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -4.60% | |
| Form 10-Q InMed Pharmaceuticals For: Dec 31 | SEC filing · Form 10-Q | -4.96% | -8.05% | |
| Form 10-Q InMed Pharmaceuticals For: Sep 30 | SEC filing · Form 10-Q | -0.27% | -5.33% | |
| Form 10-K/A InMed Pharmaceuticals For: Jun 30 | SEC filing · Form 10-K | +0.49% | -0.97% | |
| Form 10-K InMed Pharmaceuticals For: Jun 30 | SEC filing · Form 10-K | -0.14% | -3.17% | |
| Form 10-Q InMed Pharmaceuticals For: Mar 31 | SEC filing · Form 10-Q | +2.78% | +12.93% | |
| Form 10-Q InMed Pharmaceuticals For: Dec 31 | SEC filing · Form 10-Q | -0.63% | -1.59% | |
| Form 10-Q InMed Pharmaceuticals For: Sep 30 | SEC filing · Form 10-Q | -0.41% | -15.73% | |
| Form 10-K InMed Pharmaceuticals For: Jun 30 | SEC filing · Form 10-K | -5.08% | -1.25% | |
| Form 10-Q InMed Pharmaceuticals For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -2.77% | |
| Form 10-Q InMed Pharmaceuticals For: Dec 31 | SEC filing · Form 10-Q | -5.39% | -10.79% | |
| Form 10-K/A InMed Pharmaceuticals For: Jun 30 | SEC filing · Form 10-K | -4.33% | +1.35% | |
| Form 10-Q InMed Pharmaceuticals For: Sep 30 | SEC filing · Form 10-Q | -1.15% | -1.15% |
Keep exploring
More IMLFF: analyst actions → · SEC filings → · IMLFF overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Sol-Gel Technologies Ltd. - Ordinary Shares (SLGL) | 149 | 0.00% | 42% |
| BioLineRx Ltd. - American Depositary Shares (BLRX) | 148 | -0.82% | 40% |
| Akari Therapeutics Plc - American Depositary Shares (AKTX) | 146 | 0.00% | 45% |
| BeyondSpring, Inc. - Ordinary Shares (BYSI) | 146 | 0.00% | 49% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.